SCHEMBL7221012

SCHEMBL7221012

CN(C)/C=C\C(=O)c1ccncc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 4/20 1.00
RECQL P46063 2/20 0.67
MAPT P10636 10/20 0.62
RAB9A P51151 5/20 0.62
LMNA P02545 5/20 0.62
CYP1A2 P05177 3/20 0.62
HPGD P15428 3/20 0.62
CYP2C19 P33261 2/20 0.62
ALOX12 P18054 1/20 0.62
ALDH1A1 P00352 9/20 0.59
GAA P10253 4/20 0.56
NPC1 O15118 3/20 0.56
KMT2A Q03164 2/20 0.56
POLB P06746 3/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
MEN1 O00255 1/20 0.54
HSP90AA1 P07900 1/20 0.54
CYP1A1 P04798 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP1B1 Q16678 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1863 1.00 HTT (1.00) HTTRECQLMAPTRAB9ALMNA
SCHEMBL1862 1.00 HTT (1.00) HTTRECQLMAPTRAB9ALMNA
SCHEMBL23251385 0.86 MAPT (0.81) HTTRECQLMAPTRAB9ALMNA
SCHEMBL6997673 0.81 HTT (0.67) HTTMAPTLMNACYP1A2HPGD
SCHEMBL6997670 0.81 HTT (0.67) HTTMAPTLMNACYP1A2HPGD
SCHEMBL4269488 0.80 HTT (0.67) HTTRECQLMAPTRAB9ALMNA
SCHEMBL4269491 0.80 HTT (0.67) HTTRECQLMAPTRAB9ALMNA
SCHEMBL425338 0.80 RECQL (1.00) HTTRECQLMAPTRAB9ALMNA
SCHEMBL29176317 0.80 RECQL (1.00) HTTRECQLMAPTRAB9ALMNA
SCHEMBL446006 0.80 RECQL (1.00) HTTRECQLMAPTRAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6509361-B1 Inhibit the activity of p38 MAP kinase. Also contemplated by the invention are processes for the preparation of the contemplated compounds and for the use of a contemplated compound in treating a mammalian host having a p38 kinase or PHARMACIA CORPORATION 2003-01-21 US disclosed